Oncologists Reject Reps’ Advances, While Pharma Keeps Paying The Tab
This article was originally published in The Pink Sheet Daily
Executive Summary
Oncologists are the most restrictive physicians to pharma sales reps, according to a report by ZS Associates. Oncologists permit reps less than one visit a month to educate them about new drugs, but pharma continues to waste between $1 billion and $1.5 billion on infeasible sales calls.